Antinori A - Search Results

1

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.

Zaccarelli M, Lorenzini P, Tozzi V, Forbici F, Ceccherini-Silberstein F, Gori C, D'Arrigo R, Trotta MP, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of the HIV Genotype Resistance Test (GRT) at the National Institute for Infectious Diseases "Lazzaro Spallanzani". Zaccarelli M, et al. Among authors: antinori a. Infection. 2009 Jun;37(3):203-9. doi: 10.1007/s15010-008-8142-8. Epub 2009 Mar 9. Infection. 2009. PMID: 19274429

2

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Cingolani A, Antinori A, Rizzo MG, Murri R, Ammassari A, Baldini F, Di Giambenedetto S, Cauda R, De Luca A. Cingolani A, et al. Among authors: antinori a. AIDS. 2002 Feb 15;16(3):369-79. doi: 10.1097/00002030-200202150-00008. AIDS. 2002. PMID: 11834948 Clinical Trial.

3

Reduction of HIV-1 viral load in saliva by indinavir-containing antiretroviral regimen.

Liuzzi G, Chirianni A, Clementi M, Zaccarelli M, Antinori A, Piazza M. Liuzzi G, et al. Among authors: antinori a. AIDS. 2002 Feb 15;16(3):503-4. doi: 10.1097/00002030-200202150-00031. AIDS. 2002. PMID: 11834971 No abstract available.

4

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.

Mussini C, Bugarini R, Perno CF, Antinori A, Borghi V, Bertoli A, D'Arrigo R, Bedini A, Mongiardo N, Cossarizza A, Esposito R. Mussini C, et al. Among authors: antinori a. AIDS. 2002 Jul 26;16(11):1551-4. doi: 10.1097/00002030-200207260-00013. AIDS. 2002. PMID: 12131194 Clinical Trial.

5

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

Spina M, Gabarre J, Rossi G, Fasan M, Schiantarelli C, Nigra E, Mena M, Antinori A, Ammassari A, Talamini R, Vaccher E, di Gennaro G, Tirelli U. Spina M, et al. Among authors: antinori a. Blood. 2002 Sep 15;100(6):1984-8. doi: 10.1182/blood-2002-03-0989. Blood. 2002. PMID: 12200356 Free article. Clinical Trial.

6

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, Perno CF. Antinori A, et al. AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):835-8. doi: 10.1089/08892220260190308. AIDS Res Hum Retroviruses. 2002. PMID: 12201905

7

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.

Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno CF. Antinori A, et al. AIDS. 2002 Sep 27;16(14):1867-76. doi: 10.1097/00002030-200209270-00003. AIDS. 2002. PMID: 12351946

8

High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy.

Girardi E, Palmieri F, Zaccarelli M, Tozzi V, Trotta MP, Selva C, Narciso P, Petrosillo N, Antinori A, Ippolito G. Girardi E, et al. Among authors: antinori a. AIDS. 2002 Sep 27;16(14):1976-9. doi: 10.1097/00002030-200209270-00021. AIDS. 2002. PMID: 12351964 No abstract available.

9

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group. De Luca A, et al. Among authors: antinori a. Arch Intern Med. 2002 Oct 14;162(18):2125-32. doi: 10.1001/archinte.162.18.2125. Arch Intern Med. 2002. PMID: 12374521

10

Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).

Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR. Amendola A, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):488-94. doi: 10.1097/00126334-200212150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12473837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

900 results

Search Page